ArticleCancer biology & medicine2021

Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma.

Tingting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.